Literature DB >> 11228386

The economics of vaccinating restaurant workers against hepatitis A.

M I Meltzer1, C N Shapiro, E E Mast, C Arcari.   

Abstract

The economics of vaccinating restaurant workers against hepatitis A were studied using Monte Carlo simulation models, one with a restaurant-owner perspective, and one with a societal perspective. The restaurant model allowed for a different size, number of employees and employee turnover rate. Benefits were the avoidance of loss of business (including the possibility of bankruptcy) after publicity linking the restaurant to an outbreak associated with a case of hepatitis A in a food handler. Additional benefits in the societal model included reductions in costs of food handler-associated cases of hepatitis A. The outcome used was Net Present Value (NPV), allowing comparison between models. Regardless of the cost of vaccination ($50-140/employee), for a restauranteur to ensure that all employees were vaccinated at all times substantial costs were involved (i.e. negative NPV). Even a 75% probability of bankruptcy still resulted in negative NPVs at the 95th percentiles. For society, vaccination was only cost-saving (i.e. positive NPV) if done only during epidemics and if it cost < $20/employee. Vaccinating restaurant employees is unlikely to be economical from either the restaurant owner or the societal perspective, even during hepatitis A epidemics.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11228386     DOI: 10.1016/s0264-410x(00)00396-0

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  Outbreak of infection with hepatitis A virus (HAV) associated with a foodhandler and confirmed by sequence analysis reveals a new HAV genotype IB variant.

Authors:  Maria Chironna; Pierluigi Lopalco; Rosa Prato; Cinzia Germinario; Salvatore Barbuti; Michele Quarto
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

2.  Hepatitis A Infections Among Food Handlers in the United States, 1993-2011.

Authors:  Umid M Sharapov; Karine Kentenyants; Justina Groeger; Henry Roberts; Scott D Holmberg; Melissa G Collier
Journal:  Public Health Rep       Date:  2016 Jan-Feb       Impact factor: 2.792

3.  An outbreak of hepatitis A in Southern Italy: the case for vaccinating food handlers.

Authors:  R Prato; P L Lopalco; M Chironna; C Germinario; M Quarto
Journal:  Epidemiol Infect       Date:  2005-12-01       Impact factor: 2.451

4.  Outbreak of hepatitis A in two federal states of Germany: bakery products as vehicle of infection.

Authors:  K Schenkel; V Bremer; C Grabe; U Van Treeck; E Schreier; M Höhne; A Ammon; K Alpers
Journal:  Epidemiol Infect       Date:  2006-05-02       Impact factor: 2.451

5.  Foodborne outbreak of hepatitis A, November 2007-January 2008, Austria.

Authors:  D Schmid; R Fretz; G Buchner; C König; H Perner; R Sollak; A Tratter; M Hell; M Maass; M Strasser; F Allerberger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-10-11       Impact factor: 3.267

6.  The Financial Burden of Public Health Responses to Hepatitis A Cases Among Food Handlers, 2012-2014.

Authors:  Rebecca J Morey; Melissa G Collier; Noele P Nelson
Journal:  Public Health Rep       Date:  2017-06-13       Impact factor: 2.792

7.  Valuation of symptomatic hepatitis a in adults: estimates based on time trade-off and willingness-to-pay measurement.

Authors:  R Jake Jacobs; Ronald J Moleski; Allen S Meyerhoff
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 8.  A review of interventions triggered by hepatitis A infected food-handlers in Canada.

Authors:  Andrea C Tricco; Ba' Pham; Bernard Duval; Gaston De Serres; Vladimir Gilca; Linda Vrbova; Andrea Anonychuk; Murray Krahn; David Moher
Journal:  BMC Health Serv Res       Date:  2006-12-08       Impact factor: 2.655

Review 9.  Ethical considerations for mandating food worker vaccination during outbreaks: an analysis of hepatitis A vaccine.

Authors:  Janet Fleetwood
Journal:  J Public Health Policy       Date:  2021-06-29       Impact factor: 2.222

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.